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194Development of four different devices to turn over
introducer sheaths
Jan Borggrefe, MD, Helmuth Knabe, MD, Beata Hoffmann, Martin Heller, MD, and
Jost Philipp Schäfer, MD, Kiel, Germany
Introduction: We developed four prototype sheath-turning auxiliary devices (STADs) and evaluated them in an in vitro
study setup designed to enable the change of catheter direction in endovascular interventions.
Methods: Four different prototypes, A through D, of STADs were designed and created by modifying commercially
available dilators and catheters. All STADs work with different anchor-like tips to ensure ﬁxation inside the vessel at the
puncture site. The STAD is loaded into the introducer sheath, retracted with the introducer sheath, and turned at the
puncture site. The STADs were tested in an in vitro vascular study setup using bovine veins. Success rates and procedure
times were calculated, and the handling, reliability, and overall performance were evaluated. The maximum soft tissue
thickness (STTmax) applicable was tested using bovine vessels with 7-mm thickness surrounded by a soft tissue phantom
consisting of chicken breast. A retrospective cross-sectional observation in 108 patients from our center was performed to
provide mean STTmax at the common femoral artery in patients for comparison.
Results: The success rate ranged between 75% for prototype D and 90% for prototypes A and C. The procedure time
averaged 60 seconds (range, 25-165 seconds). The mean handling was rated 2.4 (good) for prototype A, 2.0 (good) for
prototype B, 2.6 (satisfactory) for prototype C, and 3.5 (poor) for prototype D. Mean reliability was rated 3.4 (satis-
factory) for prototype A, 2.0 (good) for prototype B, 1.6 (good) for prototype C, and 2.4 (good) for prototype D. Mean
overall performance was rated 2.0 (good) for prototype C, 2.6 (satisfactory) for prototype B, 3.3 (poor) for prototype D,
and 3.4 (poor) for prototype A. In the cross-sectional patient observation, the mean STTmax was 3.3 cm (range, 0,5-13
cm) with a 95% conﬁdence interval of the distribution including an STTmax of up to 8 cm. The STTmax was #5 cm in
100 of 108 patients (93%). The applicable STTmax for prototype A was 1 cm (8 of 10 successful cases), 3 cm for
prototype B (9 of 10 successful cases), 5 cm for prototype C (8 of 10 successful cases), and 3 cm for prototype D (7 of 10
successful cases).
Conclusions: All four STAD prototypes offered the ability of turning the sheaths at the puncture site in an in vitro vascular
study setup. In the future, this concept may allow routine clinical performance of turning maneuvers at the groin vascular
access site. (J Vasc Surg 2013;58:194-200.)
Clinical Relevance: We developed and tested four different turning devices that are loaded into an introducer sheath in
interventions and that enable the introducer sheath to be turned in a blood vessel. There is no standard procedure or
dedicated device on the market that allows such a function in interventional procedures, such as at the groin vascular
access site or on venous shunts. The idea is to offer a safe method to perform such procedures to facilitate angiographic
diagnostics and to improve the safety of interventions by means of reducing the number of punctures that are being
performed as well as the time of the intervention.Peripheral arterial occlusive disease (PAOD) is a
common disease associated with nicotine abuse, hyperten-
sion, and diabetes that concerns >5% of the population
aged $70 years.1-3 Because PAOD is a systemic disease,
treatment by endovascular intervention is often indicated
in the arteries of both legs at the same time.2,3 The
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://dx.doi.org/10.1016/j.jvs.2012.10.065percutaneous vascular access is to operate in one direction
only, retrograde or antegrade. If it is necessary to treat
additional lesions located in the opposite direction of the
chosen access path, a secondary puncture, usually in
another session, is performed. Complications are thus
more likely to occur because the chance of incidental
complications increases with the number of puncture sites
and interventional approaches.4,5 To minimize the proce-
dural risk and cost, the number of interventions should
be minimized.
In special indications, several catheter maneuvers have
been reported of conversion of a retrograde access to an
antegrade access by use of commercially available mate-
rials.3,6-10 The off-label use of catheters for turning maneu-
vers is limited due to the high risk of losing the vascular
access. Further, the catheters, which are not designed for
the maneuver, may compromise patient safety because
they can lead to severe vessel damage at the puncture
site. To improve safety and implement a standard for
Fig 1. Turning maneuver with prototype A. A, A sheath is placed in a blood vessel. The sheath-turning auxiliary device
(STAD) is loaded in the sheath while a guidewire can be kept in place. The split tip of the STAD spreads apart when
reaching the endovascular position. B, The STAD with the sheath is retracted. When the split tip reaches the puncture
site, the STAD and the sheath are ﬂipped as shown. C, The wire is guided into the opposite direction. D, The STAD is
pulled out.
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sheath turning auxiliary devices (STADs) enabling the
conversion of a retrograde access to an antegrade access
in the common femoral artery (CFA).
This report describes the four prototypes of these
STADs and presents experimental results of the clinical
applicability to deﬁne the clinical opportunities connected
with their development. For this purpose, we examined
the performance of preliminary handmade prototypes in
an experimental study setup. The four major end points
were to investigate the approximate success rate, the clin-
ical acceptance by a group of testing radiologists, an
approximate time range that is necessary for the proce-
dure, and the maximum applicable soft tissue thickness
(STTmax) between the cutis and the targeted vessel
because the common ﬁnding of patient adiposity might
limit the success of the procedures.
METHODS
We developed four different STAD prototypes by
modifying commercially available dilators and catheters.
These STADs have anchor-like tips that can be deployed
and removed by different mechanisms. The STADs are
loaded into the introducer sheath. When the device is in
place, the anchor can be released, and the device withthe introducer sheath can be pulled back until the anchor
reaches the inner vessel wall at the puncture site. In that
position, the anchor hooks in and ensures the introducer
sheath with the STAD will remain inside the vessel lumen.
Now, the introducer sheath with the STAD can be ﬂipped
and inserted into the vessel pointing in the opposite direc-
tion. The anchor is retracted, and the STAD is pulled out.
The STAD prototypes work in detail as follows:
STAD prototype A. The tip of a dilator was truncated
and split into half for a length of 3 mm and shaped and
tempered by heating in a water quench to ensure that
both parts stayed in shape apart from each other, creating
a bird’s wing-like tip (Fig 1). The new tips are semirigid
to maintain ﬂexibility, can be pressed together in a closed
position, and can thus be loaded into the introducer
sheath. When the split tip leaves the end of the introducer
sheath, the two parts will spread apart again in an open
position. A guidewire can be kept in place. The STAD with
the sheath is retracted, and the bird’s wing-like tip ensures
ﬁxation inside the vessel at the puncture site by gentle
resistance. After guiding the wire into the opposite direc-
tion, the STAD is exchanged for a regular dilator to rein-
sert the sheath.
STAD prototype B. An incision was made at the tip
of a dilator with a reverse angle of 30 at a distance from
Fig 2. Turning maneuver with prototype B. A, The sheath-turning auxiliary device (STAD) with the sheath is
retracted after the STAD is loaded in the sheath and a hook unfolds when reaching the endovascular position. A
guidewire (not shown) can be kept in place. B, When the hook reaches the puncture site, there will be a slight
resistance. C, The STAD and the sheath are ﬂipped over, as shown. The wire (not shown) is guided into the opposite
direction. D, The STAD is pulled out after folding in the hook by pulling a suture (not shown) inside the STAD.
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conﬁguration, heating in a water quench was used. To fold
in the prototype for loading, a ﬁlament was sutured to the
barbed hook and coaxially led through the dilator’s lumen.
The STAD is loaded in the sheath with a wire in place, and
the STAD’s barbed hook is rotated to the obtuse angle of
the sheath at the puncture site. The STAD with the sheath
is retracted until the barbed hook links to the vessel wall.
After guiding the wire into the opposite direction, the
STAD can immediately be used to reinsert the sheath. By
gently pulling the sutured ﬁlament, the barbed hook is
folded in, and the STAD can be extracted.
STAD prototype C. A small latex balloon is attached
at a dilator’s tip. The balloon is inﬂated by a liquid such as
a saline solution or mixture of saline and contrast agent. At
maximum inﬂation, the balloon’s diameter is w5 mm
(Fig 3). A guidewire can be kept in place when the
STAD is loaded in the sheath. The balloon is inﬂated, and
the STAD with the sheath is retracted. The inﬂated balloon
ensures ﬁxation at the puncture site by gentle resistance
and is supposed to distribute the shear forces that are
applied onto the vessel wall. After guiding the wire in the
opposite direction, the balloon is deﬂated, and the STAD is
exchanged for a regular dilator to reinsert the sheath.
STAD prototype D. A 5-mm-long plastic stick with
two sutured ﬁlaments, one at the end and one at the center,is loosely connected to a catheter by leading the two ﬁla-
ments coaxially through it (Fig 4). The STAD is loaded
into the sheath, whereas a wire cannot be kept in place. By
pulling the ﬁlament attached to the stick’s center, the stick
is aligned perpendicularly to the sheath. The sheath with
the STAD is retracted, and the stick ensures ﬁxation at the
puncture site by gentle resistance. The sheath is ﬂipped. By
loosening the ﬁrst ﬁlament and by pulling the second ﬁla-
ment attached to the stick’s end, the STAD is straightened.
The sheath with the STAD, however, without the support
of a wire, is reinserted in the opposite direction.
The study setup. All STAD prototypes were tested on
a phantom consisting of an 8-mm-diameter bovine vein
afﬁxed in a sponge. One end of the vein was occluded,
and the other was connected to an infusion system wrap-
ped in a blood pressure cuff, which allowed the simulation
of blood pressure in a vessel. To keep the vein smooth and
ﬁxed, the sponge was placed in a bowl with water.
The STADS were tested by eight radiologists with
different levels of experience: four were beginners with
no endovascular experience, and four were experienced
endovascular interventionists. After the radiologists were
briefed on each prototype to familiarize themselves with
it, they each performed ﬁve turning maneuvers per
STAD. Technical success was deﬁned as a successful turn
over of the introducer sheath in the opposite direction.
Fig 3. Turning maneuver with prototype C. A, A sheath is regularly placed in a blood vessel. The sheath-turning
auxiliary device (STAD) is loaded in the sheath while a guidewire can be kept in place. B, The balloon is inﬂated
and the STAD with the sheath is retracted. C, When the inﬂated balloon reaches the puncture site, the STAD and the
sheath are ﬂipped over, as shown. D, The wire is guided into the opposite direction, the balloon is deﬂated, and the
STAD is pulled out.
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tance and their opinion of the STADs, they had to evaluate
the procedures in terms of handling (grade 1, very easy, to
grade 5, very difﬁcult), reliability (grade 1, very reliable, to
grade 5, very unreliable), and overall performance of each
STAD (grade 1, very good, to grade 5, poor).
In a second study setup, the maximum applicable
STTmax between the cutis and the vessel was tested
because massive adiposity of patients would signiﬁcantly
inhibit the turning maneuver. We aimed to quantify this
to estimate the rate of patients who could theoretically be
treated using a STAD-turning maneuver. Vessels with
a lumen of 7 mm were used because this vessel size reﬂects
the median lumen diameter of the CFA.11 The skin and the
breast of soup chickens were dissected and ﬁxed in phan-
toms with steps of 1 cm up to a total ofw8 cm. Ten repe-
titions of the turning maneuvers were performed to
determine the critical soft tissue thickness of each STAD.
Success was deﬁned for a soft tissue thickness when
>70% of the repetitions resulted in a successful turning
maneuver as deﬁned in the interuser testing.
To provide data of soft tissue thickness at the prospec-
tive puncture site in the CFA, we evaluated the average soft
tissue thickness between the anterior wall of the CFA and
the skin level (STTmax) in a retrospective cross-sectional
observation of patients in our clinic. Between March and
May 2011, 114 patients received diagnostic computed
tomography (CT) angiography for the purpose of a vascularintervention or surgery and were included in the observa-
tion. All patients gave informed consent for scientiﬁc use
of their CT data. Six patients were excluded due to artifacts
from calciﬁed high-grade CFA stenosis or hip prosthesis.
Thus, 108 patients (mean age, 71.3; range, 40-97 years)
were available for analysis.
RESULTS
The success rate for prototype A was 90% (36 of 40).
The STAD dislocated in three cases, and one failure
occurred because of an application error. The success rate
for prototype B was 87.5% (35 of 40), with three disloca-
tions and two application errors. The success rate for proto-
type C was 90% (36 of 40), with two dislocations and two
balloon bursts. Prototype D provided a success rate of 75%
(34 of 40), with three dislocations and three application
errors.
The procedure time (in seconds) for the turnover
maneuvers averaged 66 (range, 40-165) for prototype
A, 50 (range, 30-130) for prototype B, 54 (range,
25-100) for prototype C, and 70 (range, 25-150) for
prototype D.
The handling was rated on average 2.4 (good) for
prototype A, 2.0 (good) for prototype B, 2.6 (satisfactory)
for prototype C, and 3.5 (poor) for prototype D. The
average reliability was rated 3.4 (satisfactory) for prototype
A, 2.0 (good) for prototype B, 1.6 (good) for prototype C,
and 2.4 (good) for prototype D. The participants evaluated
Fig 4. Turning maneuver with prototype D. A, The sheath-turning auxiliary device (STAD) is loaded into the sheath.
B, After the ﬁlament attached to the stick’s center is pulled, (C) the sheath can be ﬂipped over.D, Consecutive removal
by pulling the ﬁlament attached to the stick’s end.
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(good), followed by prototype B at 2.6 (satisfactory),
prototype D at 3.3 (poor), and prototype A at 3.4 (poor).
The applicable STTmax was 1 cm for prototype A (8 of
10 successful cases), 3 cm for prototype B (9 of 10 success-
ful cases), 5 cm for prototype C (8 of 10 successful cases),
and 3 cm for prototype D (7 of 10 successful cases).
The mean STTmax was 3.3 cm. The 95% conﬁdence
interval of the distribution included an STTmax of up to
8 cm. The maximum STTmax value was 13 cm. Of 108
patients, 100 (93%) showed an STTmax of #5 cm.
DISCUSSION
In many patients presenting with PAOD, endovascular
intervention is indicated at two different locations at the
same time.2,3 Frequently, in cases where the lesions include
the iliac and femoral arteries of the same leg, or both legs,
two separate interventions of the same or the contralateral
leg have to be performed due to access limitations. These
additional interventions lead to an increase in hospitaliza-
tion time, socioeconomic costs, and the number of co-
mplications.3-5 The opportunity to perform therapy and
diagnostics in retrograde and antegrade directions at thesame time could allow completing many of these cases in
one procedure. Because no tool is commercially available
for a turnover maneuver at the puncture site in the CFA,
we developed four STADs.
The in vitro testing of our prototypes by eight radiolo-
gists showed good success rates for the maneuvers, ranging
from 75% to 90%. Mechanical reﬁnement and automatic
production is expected to have a major impact and should
increase the success rates. The necessary procedure times,
averaging 1 minute (range, 30-90 seconds) for each device,
were acceptable, especially when compared with a study on
catheter-based turning maneuvers by Neumann et al3 that
reported an average procedure time of 3.9 minutes for their
method. However, the early prototype character of our
devices did prolong procedures, so that faster turning
maneuvers can be assumed for reﬁned prototypes or
products.
The advantage of prototype A is its simple construction
that allowed an application on an easy-to-use basis, with
the handling rated as good in our study. However, its
reliability and overall performance were rated satisfactory,
the lowest among the tested prototypes. The major short-
coming may be explained by an only gentle increasing
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the bird’s wing-like tip ensures ﬁxation inside the vessel at
the puncture site. A more rigid tip and an implementation
of a marker bleeding, as is used in vascular closure devices,
may overcome this problem. Nevertheless, the STAD
prototype A offered a high success rate of 90%, as also
did prototype C.
Prototype B offered good handling and good reli-
ability. The elaboration is more complex because the inci-
sion at the tip of the dilator creating the barbed hook
needs to be very precise. The device provides a point of
total resistance and allows sufﬁcient ﬁxation to perform
the maneuver at a tissue depth of 3 cm, which seems
acceptable. A severe limitation is that the barbed hook
may cause intimal damage at the puncture site. In two
cases, failure of the maneuver occurred because the investi-
gator could not fold in the hook at the tip of the handmade
prototype. In clinical use, this scenario would have caused
a surgical revision as major complication.
Prototype C offered the highest reliability and was
rated best for overall performance among the tested
devices. The production is complex and resembles the
production and cost of a balloon catheter. The prototype
provided a strong and absolute resistance during the
turning maneuver with the best results in the surrounding
tissue simulation of 5 cm STTmax. A relevant risk of
intimal damage is not expected because the inﬂated balloon
size of 5 mm is undersized compared with the common
CFA diameter; thus, a potential barotrauma is unlikely.
In addition, the method of applying an inﬂated balloon
for medical purposes is routinely used such as for Fogarty
maneuvers, tracheal tubes, bladder catheters, or double-
balloon enteroscopy.
Prototype D is an elaborate tool that does not allow
easy handling. It offered only poor handling and poor over-
all performance in our study. The success rate was lowest,
with only 75% of the cases. In three cases, the STAD could
not be extracted because the locking mechanism failed,
which would have caused a surgical revision as a major
complication in clinical use. In addition, the trauma along
the intimal layer is certainly substantial when the STAD
with the sheath is reinserted in the opposite direction
without the support of a guidewire.
The evaluation of the applicability of the tested STADs
in soft tissue thickness revealed large differences, ranging
from 1 to 5 cm feasible soft tissue thickness. Because all
STADs allowed turning maneuvers in general, this effect
mainly has to be ascribed to the quality of the preliminary
prototypes being used. However, the results show that the
turning maneuvers can be performed routinely with a soft
tissue thickness of up to 5 cm. Matching this with our
cross-sectional analysis, 93% of the observed patients
from this German cohort would have been feasible for
sheath-turning maneuvers at the groin vascular access site
when considering soft tissue thickness.
Several limitations remain that will be an issue of
further investigations. We used veins in our vascular study
setup instead of arteries because these vessels, which arealso used for cardiovascular surgery, are commercially avail-
able and performed well in providing an adequate and
deﬁned vascular setting. In later studies with STADs
derived from machine production, we plan to work with
arteries in further ex vivo and in vivo studies in animals
to provide detailed information regarding the maximal
possible soft tissue thickness for the procedure, the minimal
adequate vessel size, and the histologic vascular damage
resulting from use of each of the devices.
Further, we aim to compare the success rate and the
time needed for turning maneuvers using STADS in rela-
tion to maneuvers using Omni (AngioDynamics Queens-
bury, NY) or Simmons 1-shaped catheters. For this
purpose, standardized serial production of the different
STADs is sought.
CONCLUSIONS
In this dedicated in vitro study setup, our four STAD
prototypes enabled the investigators to turn introducer
sheaths at the puncture site for the conversion of a retro-
grade access to an antegrade access. On the basis of these
promising results, we believe we have created a basic
concept for the development of a regular sheath-turning
auxiliary device for clinical use.
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